Compare PSMT & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PSMT | LIVN |
|---|---|---|
| Founded | 1994 | 1987 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Department/Specialty Retail Stores | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 3.5B |
| IPO Year | 1997 | 1993 |
| Metric | PSMT | LIVN |
|---|---|---|
| Price | $126.09 | $61.97 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $62.43 |
| AVG Volume (30 Days) | 153.3K | ★ 637.8K |
| Earning Date | 01-07-2026 | 11-05-2025 |
| Dividend Yield | ★ 2.00% | N/A |
| EPS Growth | ★ 5.57 | N/A |
| EPS | ★ 4.82 | N/A |
| Revenue | ★ $5,270,094,000.00 | $1,348,962,000.00 |
| Revenue This Year | $10.66 | $12.25 |
| Revenue Next Year | $9.64 | $6.75 |
| P/E Ratio | $26.09 | ★ N/A |
| Revenue Growth | 7.25 | ★ 8.63 |
| 52 Week Low | $81.25 | $32.48 |
| 52 Week High | $129.16 | $64.45 |
| Indicator | PSMT | LIVN |
|---|---|---|
| Relative Strength Index (RSI) | 60.01 | 64.99 |
| Support Level | $123.95 | $61.81 |
| Resistance Level | $129.16 | $64.45 |
| Average True Range (ATR) | 3.23 | 1.82 |
| MACD | 0.50 | 0.11 |
| Stochastic Oscillator | 75.87 | 86.78 |
Pricesmart Inc is principally engaged in operating U.S.-style membership shopping warehouse clubs that offer consumer goods at low prices. The company is headquartered in San Diego, California, United States, and operates stores in the Caribbean, Costa Rica, Panama, and other regions. The company's revenue consists of net warehouse club sales from merchandise sales, membership income from annual membership fees, export sales, and other income. Its operations consist of four reportable segments; Central America, the Caribbean, Colombia, and the United States. A majority of the company's revenue is derived from Central America.
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.